MedTrace Logo

Prednisolone Treatment in Acute Interstitial Nephritis

NCT04376216 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2020-12-30

No results posted yet for this study

Summary

A Prospective randomized trial with a primary objective to investigate the effect ofprdenisolone treatment in acute interstitial nephritis

Conditions

  • Acute Tubulo-Interstitial Nephritis

Interventions

DRUG

Prednisone

60 mg with dose tapering over 2 months

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • Odense University Hospital

    collaborator OTHER

  • Region MidtJylland Denmark

    lead OTHER

Principal Investigators

  • Jesper N Bech, MD · Region MidtJylland Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2026-09-01
Completion
2027-09-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04376216 on ClinicalTrials.gov